IGF-2 vs Arginine Vasopressin

Head-to-head comparison of IGF-2 (Insulin-Like Growth Factor II) and Arginine Vasopressin (8-Arginine Vasopressin) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyIGF-2Arginine Vasopressin
CategoryCognitive EnhancementCognitive Enhancement
Full NameInsulin-Like Growth Factor II8-Arginine Vasopressin
Molecular Weight7467 Da1084.23 Da
Half-Life6-10 minutes10-20 minutes
Amino Acids67 aa9
Typical Dose1-10 µg preclinical range10-40 IU intranasal research range
RouteIntranasalIntranasal/Subcutaneous
Purity≥98%≥98%
Studies Count1200100
Research StatusPre-clinicalClinical

IGF-2 Benefits

  • memory consolidation
  • hippocampal plasticity
  • synaptic repair
  • neuroprotection

Arginine Vasopressin Benefits

  • memory consolidation
  • recall support
  • arousal-linked learning
  • social cognition

IGF-2 Dosing

0.1-1 µg ICV in rodents|1-10 µg intrahippocampal in preclinical work|acute post-training protocols

Arginine Vasopressin Dosing

intranasal research dosing|10-40 IU per dose in studies|single or repeated administration

IGF-2 Side Effects

  • hypoglycemia risk
  • edema
  • insulin-like systemic effects

Arginine Vasopressin Side Effects

  • blood pressure elevation
  • headache
  • hyponatremia

Research Overview

IGF-2

IGF-2 has strong preclinical evidence for improving memory formation and supporting synaptic changes tied to learning. It also shows neuroprotective and repair-related effects in models of injury and neurodegeneration.

Arginine Vasopressin

Animal and human studies indicate vasopressin can modulate hippocampal and limbic circuits involved in learning and memory. The effect size is context dependent, and results vary by dose, route, and baseline cognitive state.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

IGF-2 stacks with:

BDNFciticolinealpha-gpc

Arginine Vasopressin stacks with:

gpenoopeptdesmopressin
memoryhippocampusgrowth-factorplasticitynonapeptideneuropeptide